Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
In April 2023, 23andMe was targeted in a hack that exposed the personal data of 6.9 million customers. The company agreed to ...
The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...
The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...
In the year since its hack, 23andMe has lost all of its value and most of its governing board — and somehow, things just keep ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback